Journal
IMMUNITY INFLAMMATION AND DISEASE
Volume 9, Issue 4, Pages 1702-1706Publisher
WILEY
DOI: 10.1002/iid3.525
Keywords
anti-SARS-CoV-2 spike antibodies; COVID-19; SARS-CoV-2; vaccine
Categories
Funding
- Volkswagen Foundation [98 579]
Ask authors/readers for more resources
The study found that individuals who were infected as early as 10 days after their first vaccine dose had antibody levels comparable to fully vaccinated individuals.
Introduction One dose of a coronavirus disease 2019 (COVID-19) vaccine can elicit high antibody titers in individuals who were previously infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, it is unclear how a SARS-CoV-2 infection shortly after a first COVID-19 vaccine dose affects antibody responses. Methods Here we investigate residents and staff of a nursing home, where a COVID-19 outbreak occurred shortly after the first BNT162b2 immunization. Results and Conclusions Our data show that individuals who got infected as early as 10 days after their first immunization show antibody levels comparable to fully vaccinated individuals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available